Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smruthy Sivakumar

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Nature Genetics|July 1, 2026
U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutationsDavid M Walter, Katherine Cho, Smruthy Sivakumar, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 21, 2025
Clinical Use of Liquid-Based Comprehensive Genomic Profiling in Gastrointestinal Stromal TumorsHiba Mechahougui, Lindsey Hildebrand, James Haberberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
Genome Medicine|April 26, 2023
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancersKatherine E Hutchinson, Jessica W Chen, Heidi M Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
NPJ Precision Oncology|November 18, 2025
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen projectTakahiro Osawa, Nobuaki Matsubara, Taigo Kato, et al.
NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Cancer Research|June 8, 2026
Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer CellsEun Jung Kim, Dexter X Jin, Alejandro M Chibly, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 1, 2018
Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung AdenocarcinomaJacob Kantrowitz, Ansam Sinjab, Li Xu, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Nature Genetics|July 1, 2026
U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutationsDavid M Walter, Katherine Cho, Smruthy Sivakumar, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 21, 2025
Clinical Use of Liquid-Based Comprehensive Genomic Profiling in Gastrointestinal Stromal TumorsHiba Mechahougui, Lindsey Hildebrand, James Haberberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
Genome Medicine|April 26, 2023
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancersKatherine E Hutchinson, Jessica W Chen, Heidi M Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
NPJ Precision Oncology|November 18, 2025
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen projectTakahiro Osawa, Nobuaki Matsubara, Taigo Kato, et al.
NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Cancer Research|June 8, 2026
Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer CellsEun Jung Kim, Dexter X Jin, Alejandro M Chibly, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 1, 2018
Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung AdenocarcinomaJacob Kantrowitz, Ansam Sinjab, Li Xu, et al.
Pageof 5